CH623321A5 - Process for the preparation of heterocyclic aminoalcohol derivatives - Google Patents

Process for the preparation of heterocyclic aminoalcohol derivatives Download PDF

Info

Publication number
CH623321A5
CH623321A5 CH1454276A CH1454276A CH623321A5 CH 623321 A5 CH623321 A5 CH 623321A5 CH 1454276 A CH1454276 A CH 1454276A CH 1454276 A CH1454276 A CH 1454276A CH 623321 A5 CH623321 A5 CH 623321A5
Authority
CH
Switzerland
Prior art keywords
radical
formula
chs
solvent
phenyl
Prior art date
Application number
CH1454276A
Other languages
English (en)
French (fr)
Inventor
George Lambelin
Joseph Roba
Romeo Roncucci
Claude Gillet
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of CH623321A5 publication Critical patent/CH623321A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
CH1454276A 1975-11-18 1976-11-18 Process for the preparation of heterocyclic aminoalcohol derivatives CH623321A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7535217A FR2332010A1 (fr) 1975-11-18 1975-11-18 Amino-alcool heterocyclique, son sel et son procede de preparation

Publications (1)

Publication Number Publication Date
CH623321A5 true CH623321A5 (en) 1981-05-29

Family

ID=9162563

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1454276A CH623321A5 (en) 1975-11-18 1976-11-18 Process for the preparation of heterocyclic aminoalcohol derivatives
CH167280A CH622770A5 (en) 1975-11-18 1980-03-03 Process for the preparation of heterocyclic aminoalcohol derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH167280A CH622770A5 (en) 1975-11-18 1980-03-03 Process for the preparation of heterocyclic aminoalcohol derivatives

Country Status (21)

Country Link
JP (2) JPS5297952A (de)
AT (1) AT355566B (de)
AU (1) AU510315B2 (de)
BE (1) BE848496A (de)
CA (1) CA1094088A (de)
CH (2) CH623321A5 (de)
DE (1) DE2651572C2 (de)
DK (1) DK151330C (de)
ES (1) ES453389A1 (de)
FI (1) FI763265A (de)
FR (1) FR2332010A1 (de)
GB (1) GB1565080A (de)
GR (1) GR62012B (de)
IE (1) IE44265B1 (de)
IL (1) IL50932A (de)
MX (1) MX4881E (de)
NL (1) NL180936C (de)
NZ (1) NZ182665A (de)
PT (1) PT65853B (de)
SE (1) SE434744B (de)
ZA (1) ZA766907B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512817A1 (fr) * 1981-09-17 1983-03-18 Roussel Uclaf Nouveaux derives de l'aminomethyl 1h-indole-4-methanol et leurs sels, leur procede de preparation, leur application a titre de medicaments, les compositions les renfermant et leurs intermediaires de preparation
US4562200A (en) * 1983-06-30 1985-12-31 American Home Products Corporation 5(Indolyl) and 5(2,3-dihydroindolyl) substituted aminoethanols and their use as anti-hypertensives
US4521606A (en) * 1983-06-30 1985-06-04 American Home Products Corp. 5-Indolyl substituted aminoethanols
US4622399A (en) * 1983-06-30 1986-11-11 American Home Products Corporation Bicyclo-heterocyclic nitrogen substituted aminoethanol derivatives
ATE194982T1 (de) 1992-04-24 2000-08-15 Takeda Chemical Industries Ltd Benzoxazepin-derivate als cholinesterase- inhibitoren
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5656661A (en) * 1994-07-27 1997-08-12 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5684002A (en) * 1994-09-07 1997-11-04 The Procter & Gamble Company Dihydorbenzofuran and related compounds useful as anti-inflammatory agents
AU715233B2 (en) 1996-01-10 2000-01-20 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
US5672620A (en) * 1996-02-01 1997-09-30 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5684031A (en) * 1996-02-01 1997-11-04 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
FR2758820B1 (fr) * 1997-01-30 1999-02-26 Synthelabo Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique
AU6218598A (en) * 1997-01-30 1998-08-25 Synthelabo Alpha-azacyclomethyl benzothiophene and alpha-azacyclomethyl benzofurane derivatives, preparation and therapeutic application
DE997458T1 (de) * 1997-07-03 2001-03-01 Asahi Chemical Ind Tricyclische verbindungen mit gesättigten ringen und diese enthaltende medizinische zubereitungen
PT1277736E (pt) 2000-04-28 2007-10-12 Asahi Kasei Pharma Corp Novos compostos bicíclicos
ES2309200T3 (es) 2001-10-25 2008-12-16 Asahi Kasei Pharma Corporation Compuesto biciclico.
AU2009301797B2 (en) 2008-10-09 2012-03-01 Asahi Kasei Pharma Corporation Indazole derivative
US8008506B2 (en) 2008-10-09 2011-08-30 Asahi Kasei Pharma Corporation Indazole compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1013224A (en) * 1962-06-21 1965-12-15 Ici Ltd Heterocyclic aminoethanols
US3255249A (en) * 1963-04-26 1966-06-07 Ici Ltd 2-branched lower alkyl-amino-1-(indan-, hydrogenated indan- and hydrogenated naphth-2-yl) lower alkanols
CH442302A (de) * 1964-04-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Indolderivates
FR2138488A1 (en) * 1971-05-27 1973-01-05 Lipha 1-(5-indanyl)-omega-aminoalkanes - with tranquillizing activity

Also Published As

Publication number Publication date
DE2651572C2 (de) 1982-05-19
JPS5297952A (en) 1977-08-17
FR2332010B1 (de) 1979-06-29
DE2651572A1 (de) 1977-06-08
DK151330C (da) 1988-04-25
IL50932A (en) 1984-01-31
GR62012B (en) 1979-02-15
JPS57145843A (en) 1982-09-09
CA1094088A (en) 1981-01-20
JPS6017778B2 (ja) 1985-05-07
CH622770A5 (en) 1981-04-30
NL7612794A (nl) 1977-05-23
IE44265L (en) 1977-05-18
ES453389A1 (es) 1977-11-16
IE44265B1 (en) 1981-09-23
GB1565080A (en) 1980-04-16
PT65853A (fr) 1976-12-01
AT355566B (de) 1980-03-10
ZA766907B (en) 1977-10-26
DK517076A (da) 1977-05-19
FR2332010A1 (fr) 1977-06-17
NL180936B (nl) 1986-12-16
ATA854376A (de) 1979-08-15
PT65853B (fr) 1978-05-15
SE434744B (sv) 1984-08-13
MX4881E (es) 1982-11-30
NZ182665A (en) 1978-11-13
AU1977976A (en) 1978-05-25
FI763265A (de) 1977-05-19
DK151330B (da) 1987-11-23
SE7612554L (sv) 1977-05-19
IL50932A0 (en) 1977-01-31
BE848496A (fr) 1977-05-18
JPS63435B2 (de) 1988-01-07
AU510315B2 (en) 1980-06-19
NL180936C (nl) 1987-05-18

Similar Documents

Publication Publication Date Title
CH623321A5 (en) Process for the preparation of heterocyclic aminoalcohol derivatives
EP0205375B1 (de) Chinolinamidderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0465358B1 (de) 2-Thienylglycidsäurederivat, Verfahren zu seiner Herstellung und seine Verwendung als Synthesezwischenprodukt
FR2670491A1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2642069A1 (fr) Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2618437A1 (fr) Nouveaux derives du benzopyranne, leur preparation et les medicaments qui les contiennent
EP0424243B1 (de) 3-Aryl-Oxazolidinone, Verfahren zu ihrer Herstellung und ihre Anwendung in der Therapie
FR2584723A1 (fr) Nouveaux derives du dihydro-2,3 benzofuranne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
CA2143252C (fr) Derives de benzodioxane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2468601A1 (fr) Nouveaux derives de flavanne utiles notamment comme anticonvulsivants
EP0486386A2 (de) Neue N-Benzoylprolin-Derivate, Verfahren zur Herstellung und diese enthaltende Arzneimittel
EP0286515B1 (de) Tricyclische 5,6,7,8-Tetrahydro-naphtho [2,3b]-2,3-dihydrofuran- und 6,7,8,9-Tetrahydro-5H-benzocyclohepta [2,3b]-2,3-dihydrofuranaminderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
FR2729142A1 (fr) Nouvelles amines heterocycliques, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu'agents anti-arythmiques
FR2862971A1 (fr) Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
EP0998471B1 (de) Heterozyclische verbindungen, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
EP0002978B1 (de) Thiazolidindion-2,4 Derivate, deren Herstellung und Verwendung als Arzneimittel
CA2030732C (fr) Nouveaux derives du thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2702214A1 (fr) Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
CA2256247C (fr) Nouveaux composes heterocycliques, leur procede de praparation et les compositions pharmaceutiques qui les contiennent
EP0384843B1 (de) 1-Arylsulfonyl-2-piperidinon-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen
EP0599697A1 (de) Pyrrol-Derivate, ihre Herstellung und therapeutische Verwendung
FR2712886A1 (fr) Dérivés de 1,3,4-oxadiazol-2(3H)-one, leur préparation et leur application en thérapeutique.
EP0686637B1 (de) Tetracyclische 1,4-Oxazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
FR2587333A1 (fr) Nouveaux ethers allyliques bicycliques, leur preparation et leur utilisation comme anti-fongiques et fongicides
EP0259228B1 (de) 5-Aminomethyl-2-oxazolidinon-Derivate, ihre Herstellung und ihre Anwendung in der Heilkunde

Legal Events

Date Code Title Description
PUE Assignment

Owner name: CONTINENTAL PHARMA, INC.

PL Patent ceased